Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Harnessing regulatory T cells to establish immune tolerance.
Journal: Science translational medicine
Published: March 13, 2024
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
Journal: JACC. Cardiovascular interventions
Published: April 20, 2016
Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: November 22, 2013
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
Journal: American heart journal
Published: February 01, 2013
The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical development.
Journal: American heart journal
Published: January 17, 2013
Showing 1-5 of 5
Last Updated: 09/26/2026